Spotlight on the
news
of the Cimi

« Malaria, asplenia : a story of sensing, swelling, sickling & pitting »

« Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses »

Residency and trafficking of ILC2 under stable and Th2-induced inflammatory conditions

TBC

TBC

Scientist and Christian: where is the problem?

Human pathogenic fungus Candida albicans

SARS-CoV2 and T cell response

The early immune response after SARS-Cov-2 infection

The effectiveness of a vaccine against #HIV

Dr Behazine Combadière, a lead investigator at the Centre for Immunology and Infectious Diseases @INSERM is working on predicting the effectiveness of a vaccine against #HIV which is concurrently advancing the #CovidVaccine development research.

Vaccine responses against SARS-CoV-2 variants examined in people with lupus

The majority of people with systemic lupus erythematosus (SLE) who respond to messenger (m)RNA COVID-19 vaccines also generate an antibody response against emerging SARS-CoV-2 variants, albeit with reduced neutralizing activity against variants bearing the E484K mutation, researchers report.

Is it dangerous to be vaccinated if you have already had the coronavirus?

A message received by the editorial staff of LCI.fr is concerned about the possible danger of a vaccine against Covid-19 for people already infected. We respond with Béhazine Combadière, director of research at Inserm.

Covid-19: a needle-free vaccination soon possible?

To meet the demand for vaccines, and to avoid a possible shortage of needles and syringes, start-ups, with the support of certain countries such as Canada, are working on injection methods that are not intramuscular, but through the skin.